Subo Liao

The novel benzopyran class of selective cyclooxygenase-2 inhibitors. Part 2: The second clinical candidate having a shorter and favorable human half-life

Jane L. Wang, David C. Limburg, Matthew J. Graneto et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 324 citations · Full text

Medicinal Chemistry, Novel Benzopyran Class, Favorable Human Half-life +11

De Novo Design, Synthesis, and Biological Activities of High-Affinity and Selective Non-Peptide Agonists of the δ-Opioid Receptor

Subo Liao, Josue Alfaro-Lopez, Mark D. Shenderovich et al. · Journal of Medicinal Chemistry · 1998 · 66 citations · Full text

Syntheses of highly constrained β-aryl isohexanoic acid derivatives via asymmetric Michael addition

Subo Liao, Yinglin Han, Wei Qui et al. · Tetrahedron Letters · 1996 · 42 citations

Derivatives, Engineering, Organic Chemistry +6

A three-dimensional model of the δ-opioid pharmacophore: Comparative molecular modeling of peptide and nonpeptide ligands

Mark D. Shenderovich, Subo Liao, Xinhua Qian et al. · Biopolymers · 2000 · 39 citations

The stereochemical requirements of the novel δ-opioid selective dipeptide antagonist TMT-Tic

Subo Liao, Jun Lin, Mark D. Shenderovich et al. · Bioorganic & Medicinal Chemistry Letters · 1997 · 38 citations

Molecular Pharmacology, Functional Selectivity, Medicine +9